The average length of stay (ALOS) for alcoholic liver disease in UK hospitals is projected to decrease from 11.1 days in 2024 to 10.7 days by 2028. This represents a consistent annual decline, with year-on-year reductions of approximately 0.9% to 0.4%. Comparatively, in 2023, the ALOS was higher, indicating an improving efficiency in patient care or early discharge practices.
Future trends to watch include:
- Impact of advancements in liver disease treatments and early interventions.
- Policy changes affecting alcohol consumption patterns in the UK.
- Healthcare system strategies aimed at reducing inpatient duration.
